The Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018.
The Trump Administration's 2019 National Drug Control Strategy is consistent with the National Association of Chain Drug Stores' public policy recommendations, the organization said.
According to the University of Michigan Surveys of Consumers, its Sentiment Index had a reading of reading of 91.2 in January, down from 98.3 in December.